Corporate Information
CEO Message
Mission
Corporate Information
Corporate Governance
Business
Stemrim History
About “Regeneration-Inducing Medicine
™
”
What is “Regeneration-Inducing Medicine
™
”?
Issues of Conventional Cell Therapy
The Superiority of “Regeneration-Inducing Medicine
™
”
Business
Areas of Disease and Pipeline
“Regeneration-Inducing Medicine
™
”
Autologous cell sampling devices for medical treatment
Stem cells gene therapy
Research Paper
Investor Relations
COO Message
Investor News
ESG
Financial Data
Investor Library
Investor Calendar
Analyst Coverage
Stock Prices
Investor Relations
Timely Disclosure Information
July 26, 2024
StemRIM Announces Fixed Details of the Issuance of Stock Options to Employees
July 26, 2024
StemRIM Announces Fixed Details of the Issuance of Stock Options to Directors
July 25, 2024
StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to Directors
July 25, 2024
StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to Employees
July 25, 2024
StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to Temporary Employees and External Collaborator
Click here for past list
StemRIM
>
Investor Relations
>
Investor Library
>
Timely Disclosure Information
